Risk factors for repeated percutaneous transluminal angioplasty of hemodialysis vascular access after initial intervention.

Among the patients undergoing hemodialysis, the use of antiplatelet agents was associated with a lower risk of re-PTA. Therefore, the use of antiplatelet drugs may reduce the rates of re-PTA and help in maintaining the patency of vascular access.